Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Accuray | ARAY | Sep 20, 2024 | 1.73 | -8.95 |
Acelyrin | SLRN | Sep 20, 2024 | 5.39 | +1.70 |
Achieve Life Sciences | ACHV | Sep 20, 2024 | 4.60 | +0.88 |
Achilles Therapeutics ADR | ACHL | Sep 20, 2024 | 1.04 | +10.64 |
ACI Worldwide | ACIW | Sep 20, 2024 | 50.33 | +1.76 |
Aclarion | ACON | Sep 20, 2024 | 0.18 | -4.32 |
Aclaris Therapeutics | ACRS | Sep 20, 2024 | 1.15 | -4.96 |
ACM Research A | ACMR | Sep 20, 2024 | 17.04 | -2.49 |
Acme United | ACU | Sep 20, 2024 | 42.10 | -1.27 |
ACNB | ACNB | Sep 20, 2024 | 43.47 | -1.23 |
ACRES Commercial Realty | ACR | Sep 20, 2024 | 15.79 | +2.20 |
ACRES Commercial Realty C Pref | ACR-C | Sep 20, 2024 | 25.19 | -0.24 |
ACRES Commercial Realty D Pref | ACR-D | Sep 20, 2024 | 23.50 | +0.43 |
Acri Capital Acquisition Unit | ACACU | Sep 20, 2024 | 13.28 | +1.61 |
Acrivon Therapeutics | ACRV | Sep 20, 2024 | 7.47 | -1.58 |
Actelis Networks | ASNS | Sep 20, 2024 | 1.52 | +1.67 |
Actinium Pharmaceuticals | ATNM | Sep 20, 2024 | 1.80 | -4.26 |
Active Bear ETF | HDGE | Sep 20, 2024 | 19.00 | +0.85 |
Active U.S. Real Estate Powershares | PSR | Sep 20, 2024 | 98.74 | -0.33 |
Actuate Therapeutics | ACTU | Sep 20, 2024 | 7.31 | 0.00 |
Acuity Brands | AYI | Sep 20, 2024 | 272.23 | +0.09 |
Acumen Pharmaceuticals | ABOS | Sep 20, 2024 | 2.50 | -3.10 |
Acurx Pharmaceuticals | ACXP | Sep 20, 2024 | 2.01 | -1.47 |
Acushnet | GOLF | Sep 20, 2024 | 63.37 | -1.35 |
ACV Auctions A | ACVA | Sep 20, 2024 | 20.75 | +0.39 |
ACWI Ex-US Index MSCI Ishares | ACWX | Sep 20, 2024 | 55.73 | -0.73 |
ACWI Index MSCI Ishares | ACWI | Sep 20, 2024 | 117.76 | -0.40 |
Adagene ADR | ADAG | Sep 20, 2024 | 2.40 | +6.67 |
Adagio Medical | ADGM | Sep 20, 2024 | 3.85 | 0.00 |
Adamas One | JEWL | Sep 20, 2024 | 0.38 | 0.00 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.